Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic T cell expansion during localized viral infection.
Haanen JB, Toebes M, Cordaro TA, Wolkers MC, Kruisbeek AM, Schumacher TN. Haanen JB, et al. Eur J Immunol. 1999 Apr;29(4):1168-74. doi: 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J. Eur J Immunol. 1999. PMID: 10229083 Free article.
Tracing and characterization of the low-avidity self-specific T cell repertoire.
de Visser KE, Cordaro TA, Kioussis D, Haanen JB, Schumacher TN, Kruisbeek AM. de Visser KE, et al. Among authors: haanen jb. Eur J Immunol. 2000 May;30(5):1458-68. doi: 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 10820394 Free article.
Optimizing the efficacy of epitope-directed DNA vaccination.
Wolkers MC, Toebes M, Okabe M, Haanen JB, Schumacher TN. Wolkers MC, et al. Among authors: haanen jb. J Immunol. 2002 May 15;168(10):4998-5004. doi: 10.4049/jimmunol.168.10.4998. J Immunol. 2002. PMID: 11994451
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
Haanen JB, Baars A, Gomez R, Weder P, Smits M, de Gruijl TD, von Blomberg BM, Bloemena E, Scheper RJ, van Ham SM, Pinedo HM, van den Eertwegh AJ. Haanen JB, et al. Cancer Immunol Immunother. 2006 Apr;55(4):451-8. doi: 10.1007/s00262-005-0018-5. Epub 2005 Jul 21. Cancer Immunol Immunother. 2006. PMID: 16034562 Free PMC article. Clinical Trial.
Design and use of conditional MHC class I ligands.
Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, van de Kasteele W, Rimmelzwaan GF, Haanen JB, Ovaa H, Schumacher TN. Toebes M, et al. Among authors: haanen jb. Nat Med. 2006 Feb;12(2):246-51. doi: 10.1038/nm1360. Epub 2006 Feb 5. Nat Med. 2006. PMID: 16462803
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma.
Jorritsma A, Gomez-Eerland R, Dokter M, van de Kasteele W, Zoet YM, Doxiadis II, Rufer N, Romero P, Morgan RA, Schumacher TN, Haanen JB. Jorritsma A, et al. Among authors: haanen jb. Blood. 2007 Nov 15;110(10):3564-72. doi: 10.1182/blood-2007-02-075010. Epub 2007 Jul 27. Blood. 2007. PMID: 17660381 Free article.
In vivo antigen stability affects DNA vaccine immunogenicity.
Bins AD, Wolkers MC, van den Boom MD, Haanen JB, Schumacher TN. Bins AD, et al. Among authors: haanen jb. J Immunol. 2007 Aug 15;179(4):2126-33. doi: 10.4049/jimmunol.179.4.2126. J Immunol. 2007. PMID: 17675471
436 results